Case Control Study
Copyright ©The Author(s) 2025.
World J Hepatol. Jul 27, 2025; 17(7): 108850
Published online Jul 27, 2025. doi: 10.4254/wjh.v17.i7.108850
Figure 2
Figure 2 Comparison of serum biomarker levels among study groups assessed by Kruskal-Wallis test. A: The level of serum extra spindle pole bodies-like 1 (ESPL1) protein; B: The level of serum p53 antibody. ESPL1: Extra spindle pole bodies-like 1 CHB: Chronic hepatitis B; HBV-LC: Hepatitis B virus-related liver cirrhosis; HBV-HCC: Hepatitis B virus-related hepatocellular carcinoma; ns: Not significant.